Annual meeting canceled amid global viral outbreak.
The announcement came Thursday that HIMSS will cancel its 2020 Global Health Conference & Exhibition. The decision comes on the tail of recent reports from the World Health Organization and Centers for Disease Control & Prevention on the spread and impact of COVID-19.
As of yet, no rescheduling information has been released. But, according to the organization, a lack of suitable venues and the difficulty in coordinating speaker and exhibitor availabilities make it unlikely that the conference will be rescheduled for later this year.
HIMSS officials cited an increased understanding of the potential spread of the virus over the past 24 hours, as well as the unique medical profile of conference attendees as underlying reasons to cancel. With these factors in play, they said, it isn’t currently possible to fully assess the risks posed to participants, and continuing as planned could have placed undo stress on the local health system in Orlando.
This will be the first time in 58 years HIMSS will have canceled the event, and Hal Wolf, HIMSS president and CEO acknowledged all the effort behind planning the conference until this point.
“We recognize all the hard work that so many have put into preparing for their presentations and panels that accompany every HIMSS conference,” he said. “Based on evaluation of evolving circumstances and coordination with an external advisory panel of medical professional to support evidence-based decision making it is clear that it would be an unacceptable risk to bring so many thousands of people together in Orlando next week.”
HIMSS officials have posted additional information about travel and registration reimbursements on its website.
MRI Long Covid Study Reveals Link Between Lower Pulmonary Gas Exchange and Cognitive Dysfunction
November 26th 2024For patients with Long Covid, lower pulmonary gas exchange may be associated with lower gray and white matter volume, according to new MRI research to be presented at the Radiological Society of North America (RSNA) conference.
New DEXA Scan Study Links Thyroid Medication Levothyroxine to Higher Bone Loss Risk in Seniors
November 25th 2024Use of the medication levothyroxine, commonly prescribed for hypothyroidism, was associated with greater long-term loss of total body bone mass in seniors, according to new DEXA research to be presented at the Radiological Society of North America (RSNA) conference.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.